The FDA has approved Furoscix (furosemide injection) for the treatment of congestion due to fluid overload in adult patients with NYHA Class II and Class III chronic heart failure.
Glioblastoma Multiforme (GBM) Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
PALM BEACH, Fla., Dec. 17, 2020 /PRNewswire/ Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor in humans that involves glial cells. GBM is present in two variants namely, giant cell glioblastoma and gliosarcoma. Gliomas are tumors arising from glial cells and may occur in the spinal cord or the brain, the latter being more common. Gliomas are the most common type of brain tumor and can be either supratentorial or infratentorial. Seizure, nausea, headache, hemiparesis and memory loss are some of the common symptoms observed in the patients suffering from GBM. GBM is most commonly found in male with the age of 65 years and above. Increasing habits of alcohol consumption, changing lifestyle and increasing incidence of seizure are some of the drivers for the growth of GBM market. GBM is generally treated by first surgically removing the tumor then t
By clicking OK or continuing to use this site, you agree that we may collect and use your personal data and set
cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies,
please read our Privacy Policy and
Cookie Policy. OK By clicking OK or continuing to use this site, you agree that we may collect and use your personal data and set
cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies,
please read our Privacy Policy and
Cookie Policy.
Search